29.11.2012 Views

Oral and Poster Abstracts

Oral and Poster Abstracts

Oral and Poster Abstracts

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

2 University of Nottingham, Department of Veterinary Medicine,<br />

Nottingham, United Kingdom<br />

3 Orchard Veterinary Group, Glastonbury, United Kingdom<br />

4 Quality Milk Management Services Ltd., Wells, United Kingdom<br />

Objectives: The primary objective of the study was to determine the<br />

impact of the duration of treatment on the efficacy of penethamate<br />

hydriodide (Mamyzin ® Injection) in the cure of persistent bovine intramammary<br />

infection in U.K. dairy cows.<br />

Materials <strong>and</strong> Methods: Cows with a history of a high somatic cell count<br />

(SCC), four functional quarters, no significant teat lesions <strong>and</strong> in good<br />

general health were enrolled into a treatment study (n=95). Two different<br />

regimes were assessed using penethamate hydriodide, which was<br />

administered either as a four-day (“on-label”) course or a seven-day<br />

(“extended”) course. Intra-mammary infection status was monitored<br />

using both bacteriology <strong>and</strong> quarter somatic cell counting from 1-week<br />

pre-treatment until 4-weeks post-treatment. Multi-level statistical models<br />

were specified <strong>and</strong> interpreted within a Bayesian framework to estimate<br />

the probability of a difference between the two treatment groups<br />

(expressed as an odds ratio), using a flat, normal prior distribution.<br />

Results: Preliminary results have shown that both treatment groups<br />

experienced a significant reduction in the prevalence of gram-positive<br />

major pathogens from before until after treatment accompanied by a<br />

fall in somatic cell counts at both the quarter <strong>and</strong> cow level. There was<br />

a reduced odds of identifying a major pathogen after treatment in<br />

quarters treated for 7 days compared to quarters treated for 4 days<br />

(mean odds ratio = 0.57) <strong>and</strong> a posterior probability of 93% that<br />

treatment for 7 days resulted in fewer quarters with major pathogens<br />

than treatment for 4 days. There was an increased odds that quarters<br />

would remain below 200,000 cells/ml for 28 days after treatment for 7<br />

days compared to treatment for 4 days (odds ratio = 1.87) <strong>and</strong> a<br />

posterior probability of 79% that treatment for 7days resulted in fewer<br />

quarters > 200,000 cells/ml than treatment for 4 days.<br />

Conclusion: This study demonstrates the efficacy of Mamyzin ®<br />

Injection in the treatment of persistent IMI in dairy cows in the U.K.<br />

<strong>and</strong> has identified an increased probability of a cure when using a 7day,<br />

extended therapy regime, compared to 4-day, on-label treatment<br />

regime. In addition, the results can be used to inform clinical decisionmaking<br />

for the treatment of high SCC cows.<br />

Key words: somatic cell count, penethamate hydriodide, extended<br />

therapy, persistent infection, streptococcus uberis<br />

172 Challenge with Streptococcus uberis to Evaluate the Efficacy<br />

of Teat Sealers in Preventing Mastitis<br />

N. Williamson, K. Petrovski, C. Fern<strong>and</strong>ez<br />

Massey University, Institute of Veterinary, Animal <strong>and</strong> Biomedical<br />

Sciences, Palmerston North, New Zeal<strong>and</strong><br />

External teat sealers based on tetrahydrofuran (DryFlex (DF)) <strong>and</strong> a<br />

wound seal for humans 2-octylcyanoacrylate (B<strong>and</strong>-Aid (BA)) to prevent<br />

dry period mastitis were investigated. Streptococcus uberis has the<br />

highest incidence in the dry period <strong>and</strong> early lactation in New Zeal<strong>and</strong>. It<br />

is a ubiquitous environmental pathogen, is normally easy to cure using<br />

antibiotics <strong>and</strong> thus was an appropriate challenge organism. Quarter milk<br />

samples were taken for bacteriological culture from 175 cows, 4 <strong>and</strong> 1<br />

days before dry-off <strong>and</strong> twice within 4 days after calving. After the last<br />

milking, 88 cows received DF <strong>and</strong> 87 cows received BA. Pairs of contralateral<br />

quarters were r<strong>and</strong>omly assigned to the treated or the control group.<br />

All quarters were dipped in a Strep. uberis broth 2 <strong>and</strong> 4 days after dry-off<br />

<strong>and</strong> were assessed daily for clinical mastitis. Clinical mastitis iwas<br />

greatest 6-11 days after dry-off in both groups. Strep. uberis was the most<br />

prevalent bacterium isolated. In the DF group, 35 cases of clinical mastitis<br />

occurred in 176 treated quarters, compared with 83 in the 176 control<br />

quarters. In the BA group, 67 cases of clinical mastitis occurred in 174<br />

treated quarters, compared with 64 in 174 control quarters. DryFlex reduced<br />

mastitis after dry-off but not after calving. Octylcyanoacrylate did not<br />

reduce clinical mastitis after dry-off. A DryFlex type teat sealer showed<br />

potential in preventing mastitis in the early dry period, but has now been<br />

withdrawn worldwide. The effect of experimentally induced clinical<br />

mastitis in the early dry period on the subsequent lactation was examined.<br />

Cows (127) developing clinical mastitis after challenge were treated with<br />

antibiotic. Yields of milk, fat, protein <strong>and</strong> milk solids were analysed with<br />

respect to treatment group. No significant effect of treatment group on<br />

lactation yields of milk, fat, protein or milk solids occurred. No difference<br />

in production occurred (milk yield, 5126 vs. 5010 litres; fat yield, 267 vs.<br />

264 kg; protein yield, 182 vs. 179 kg) between cows that had mastitis <strong>and</strong><br />

52 XXV. Jubilee World Buiatrics Congress 2008<br />

those that did not. Promptly treated clinical mastitis due to Strep. uberis<br />

did not affect production in the subsequent lactation. The ability to<br />

demonstrate differences in efficacy <strong>and</strong> absence of production effects in<br />

the subsequent lactation mean this challenge model appears suitable for<br />

evaluating teat sealers.<br />

Key words: mastits, Streptococcus uberis, teat sealer<br />

173 Use of Leukocyte Differential Patterns to Optimize Diagnosis<br />

of Bovine Intramammary Infections: Evaluation of<br />

Partitioned vs. Non-partitioned Testing<br />

A. Rivas 1 , K. Anderson 1 , G. Leitner 2 , M. Chaffer 2 , O. Krifucks 2 ,<br />

R. Rodriguez 1<br />

1 North Carolina State University, College of Veterinary Medicine,<br />

Raleigh, NC, United States<br />

2 Kimron Veterinary Institute, Bacteriology,Beit-Dagan, Israel<br />

Objectives: To explore the use of leukocyte patterns in diagnosing<br />

infectious mastitis.<br />

Materials <strong>and</strong> methods: Quarter milk samples were investigated in 3<br />

cross-sectional studies conducted in the US (study I, n=120; <strong>and</strong> study<br />

III, n=500) <strong>and</strong> Israel (study II, n=484). The somatic cell count (SCC),<br />

milk microbiological cultures, <strong>and</strong> the percentages, total counts <strong>and</strong><br />

relative proportions of lymphocytes, macrophages <strong>and</strong> neutrophils<br />

were established. Non-periparturient (studies I <strong>and</strong> III) <strong>and</strong><br />

periparturient (study II) cows were assessed. Samples were collected<br />

without (studies I <strong>and</strong> III) <strong>and</strong> with previous determination of health<br />

status (study II). Disease prevalence was >40% (study I) <strong>and</strong>

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!